<html><head><title>Construct a Single-stage Design for a Time to Event
Endpoint Versus a Known Control Standard</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<link rel="stylesheet" type="text/css" href="Rchm.css">
</head>
<body>

<table width="100%"><tr><td>FixDes(OptimPhase2)</td><td align="right">R Documentation</td></tr></table><object type="application/x-oleobject" classid="clsid:1e2a7bd0-dab9-11d0-b93a-00c04fc99f9e">
<param name="keyword" value="R:   FixDes">
<param name="keyword" value=" Construct a Single-stage Design for a Time to Event
Endpoint Versus a Known Control Standard">
</object>


<h2>Construct a Single-stage Design for a Time to Event
Endpoint Versus a Known Control Standard</h2>


<h3>Description</h3>

<p>
Find the sample size, duration of accrual, and test boundary for a single-stage
design with an event-free endpoint versus a known control standard.
Testing is one-sided based on the Kaplan-Meier estimator evaluated at a
user-specified time point.
</p>


<h3>Usage</h3>

<pre>
FixDes(B.init, m.init, alpha, beta, param, x)
</pre>


<h3>Arguments</h3>

<table summary="R argblock">
<tr valign="top"><td><code>B.init</code></td>
<td>
A vector of user-specified time points (B1, ..., Bb) that determine a
set of time intervals with uniform accrual.</td></tr>
<tr valign="top"><td><code>m.init</code></td>
<td>
The projected
number of patients that can be accrued within the time intervals determined by <code>B.init</code>.</td></tr>
<tr valign="top"><td><code>alpha</code></td>
<td>
Type I error.</td></tr>
<tr valign="top"><td><code>beta</code></td>
<td>
Type II error.</td></tr>
<tr valign="top"><td><code>param</code></td>
<td>
Events should be defined as poor outcomes.  Computations 
and reporting are based on the proportion without an event at a 
pre-specified time, <code>x</code>.  For constructing an optimal design, 
complete event-free distributions at all times must be specified for 
the control condition (Null), and for
the alternative "effective" treatment.  Weibull distributions are currently
implemented.  <code>param</code> is a vector of length 4:  (shape null, 
scale null, shape alternative, scale alternative).  The R parameterization of the Weibull
distribution is used.</td></tr>
<tr valign="top"><td><code>x</code></td>
<td>
Pre-specified time for the event-free endpoint (e.g., 1 year).</td></tr>
</table>

<h3>Details</h3>

<p>
Estimation is based on the Kaplan-Meier or Nelson-Aalen estimators
evaluated at a target time (e.g., 1 year).  The event-free rates at the
target
time are computed from Weibull distributions assumed for the treated
and (assumed known) control distributions, as is done in function <code><a href="OptimDes.html">OptimDes</a></code>.
The design depends only on the event-free rates at the target time (except
for small changes due to rounding with different survivor functions).
The duration of accrual depends on the projected maximum accrual rates.
</p>


<h3>Value</h3>

<p>
A list with components:
</p>
<table summary="R argblock">
<tr valign="top"><td><code>n0</code></td>
<td>
Fixed design sample size</td></tr>
<tr valign="top"><td><code>DA</code></td>
<td>
Duration of accrual</td></tr>
<tr valign="top"><td><code>SL</code></td>
<td>
Total study length (<code>time, DA+x</code>).</td></tr>
<tr valign="top"><td><code>n0E</code></td>
<td>
n0 based on exact binomial test</td></tr>
<tr valign="top"><td><code>DAE</code></td>
<td>
DA based on exact binomial test</td></tr>
<tr valign="top"><td><code>SLE</code></td>
<td>
SL based on exact binomial test</td></tr>
<tr valign="top"><td><code>C</code></td>
<td>
Rejection cutpoint for the test statistic.</td></tr>
</table>

<h3>Note</h3>

<p>
The single-stage sample size is used as the starting value for evaluating the
optimal <code>n</code> for a two-stage design in <code><a href="OptimDes.html">OptimDes</a></code>.
</p>


<h3>Author(s)</h3>

<p>
Bo Huang <a href="mailto:&lt;bo.huang@pfizer.com&gt;">&lt;bo.huang@pfizer.com&gt;</a> and Neal Thomas <a href="mailto:&lt;neal.thomas@pfizer.com&gt;">&lt;neal.thomas@pfizer.com&gt;</a>
</p>


<h3>References</h3>

<p>
Case M. D. and Morgan T. M. (2003) Design of Phase II cancer trials
evaluating survival probabilities. <EM>BMC Medical Research
Methodology</EM>, <B>3</B>, 7.
</p>
<p>
Lin D. Y., Shen L., Ying Z. and Breslow N. E. (1996) Group seqential
designs for monitoring survival probabilities. <EM>Biometrics</EM>,
<B>52</B>, 1033&ndash;1042.
</p>
<p>
Simon R. (1989) Optimal two-stage designs for phase II clinical
trials. <EM>Controlled Clinical Trials</EM>, <B>10</B>, 1&ndash;10.
</p>


<h3>See Also</h3>

<p>
<code><a href="OptimDes.html">OptimDes</a></code>, <code><a href="Test2stage.html">Test2stage</a></code>, <code><a href="SimDes.html">SimDes</a></code>
</p>


<h3>Examples</h3>

<pre>
B.init &lt;- c(1, 2, 3, 4, 5)
m.init &lt;- c(15, 20, 25, 20, 15)
alpha &lt;- 0.05
beta &lt;- 0.1
param &lt;- c(1, 1.09, 2, 1.40)
x &lt;- 1

# H0: S0=0.40 H1: S1=0.60

FixDes(B.init, m.init, alpha, beta, param, x)

</pre>



<hr><div align="center">[Package <em>OptimPhase2</em> version 1.8 <a href="00Index.html">Index]</a></div>

</body></html>
